News
Gilead and LEO Pharma to accelerate development of oral STAT6 program with potential in...
Gilead Sciences and LEO Pharma have announced a strategic partnership to accelerate the development and commercialization of LEO Pharma’s small molecule oral STAT6 (signal transducer...
Newron and Myung In Pharm announce license agreement for schizophrenia treatment in South Korea
Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous system, and Myung In...
Er-Kim signs distribution agreement with the MEDICE Health Family for Vafseo in Central &...
Er-Kim, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, has signed a distribution agreement with the MEDICE...
